Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP642083.RAino2PkUMBTMV5D6GRoda8tYRKgguIv3GVrQ8QfN2R-w130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP642083.RAino2PkUMBTMV5D6GRoda8tYRKgguIv3GVrQ8QfN2R-w130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP642083.RAino2PkUMBTMV5D6GRoda8tYRKgguIv3GVrQ8QfN2R-w130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP642083.RAino2PkUMBTMV5D6GRoda8tYRKgguIv3GVrQ8QfN2R-w130_provenance.
- befree-20150227 importedOn "2015-02-27" NP642083.RAino2PkUMBTMV5D6GRoda8tYRKgguIv3GVrQ8QfN2R-w130_provenance.
- NP642083.RAino2PkUMBTMV5D6GRoda8tYRKgguIv3GVrQ8QfN2R-w130_assertion wasGeneratedBy ECO_0000203 NP642083.RAino2PkUMBTMV5D6GRoda8tYRKgguIv3GVrQ8QfN2R-w130_provenance.
- NP642083.RAino2PkUMBTMV5D6GRoda8tYRKgguIv3GVrQ8QfN2R-w130_assertion wasDerivedFrom befree-20150227 NP642083.RAino2PkUMBTMV5D6GRoda8tYRKgguIv3GVrQ8QfN2R-w130_provenance.
- NP642083.RAino2PkUMBTMV5D6GRoda8tYRKgguIv3GVrQ8QfN2R-w130_assertion SIO_000772 22021366 NP642083.RAino2PkUMBTMV5D6GRoda8tYRKgguIv3GVrQ8QfN2R-w130_provenance.
- NP642083.RAino2PkUMBTMV5D6GRoda8tYRKgguIv3GVrQ8QfN2R-w130_assertion evidence source_evidence_literature NP642083.RAino2PkUMBTMV5D6GRoda8tYRKgguIv3GVrQ8QfN2R-w130_provenance.
- NP642083.RAino2PkUMBTMV5D6GRoda8tYRKgguIv3GVrQ8QfN2R-w130_assertion description "[Altogether, our data suggest that AMPK is an attractive target for the treatment of BCR-ABL-expressing malignancies and raise the potential for use of AMPK activators in the treatment of refractory chronic myeloid leukemia and Ph(+) acute lymphoblastic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP642083.RAino2PkUMBTMV5D6GRoda8tYRKgguIv3GVrQ8QfN2R-w130_provenance.